Iqvia – Part 1 – RFP Volumes, Order Book Growth & Labour Dynamics

  • Public Equity
  • Healthcare
  • Europe


Former senior executive at Iqvia Inc


  • Impact of current R&D funding environment on trial sponsor demand for CRO (contract research organisation) services and RFP (request for proposal) volumes
  • Order book growth outlook, revenue conversion and potential for cancellation of contracted work
  • Ability of CRO services providers to meet demand in light of labour shortages and cost pass-through dynamics
  • Iqvia’s (NYSE: IQV) Q3 2022 performance and exposure to aforementioned market pressures


Gain access to Premium Content

Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.

    One week, unlimited access to over 40,000 transcripts
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited